Sign In or Register

Biotech News

Biotech news continually updated from thousands of sources around the net.

This blog is one of the best biotechnology blogs out there. Add this blog to My Feeds.

Genentech Provides Update On Phase III Study Of Avastin In Men With Late Stage Prostate Cancer

Mar 14, 2010 5:55am

Genentech, Inc., a wholly owned member of the Roche Group , announced today the topline results of a Phase III trial led by the U.S. Cancer and Leukemia Group B and sponsored by the National Cancer Institute investigating the use of Avastin in combination with docetaxel chemotherapy and prednisone in...

Battelle, IBM, Merck join UPMC's effort to produce vaccines

Mar 14, 2010 12:39am

The $8-billion non-profit integrated global health enterprise headquartered in Pittsburgh, Pennsylvania, UPMC, yesterday said that it has been joined by the world's largest independent researcher Battelle, IBM and Merck & Co Inc, in a first-of-its-kind initiative to establish a flexible vaccine development and production facility....

Caraco Pharmaceutical Laboratories Ltd declares launch of generic Eloxatin

Mar 13, 2010 8:24pm

Generic pharmaceuticals provider Caraco Pharmaceutical Laboratories Ltd said on Thursday that the company has introduced 50mg and 100mg oxaliplatin injections....

Positive results from BioSante Pharmaceuticals' GVAX Leukemia vaccine human clinical study

Mar 13, 2010 4:18pm

BioSante Pharmaceuticals, Inc. today announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia patients taking the drug Gleevec ....

Chattem acquisition complete

Mar 13, 2010 12:16pm

Staff Photo by Dan Henry Minnnied Hyter, left, and Cassandra Lee watch for label quality as bottles of Selsun Blue pass by at the Chattem plant....

Pfizer Discontinues a Phase 3 Study of Figitumumab in Previously...

Mar 13, 2010 7:53am

Mar 11, 2010 - Pfizer Inc. announced today the discontinuation of A4021018 , a Phase 3 trial examining the effects of investigational compound figitumumab in combination with erlotinib as a second/third-line treatment in patients with previously treated advanced non-adenocarcinoma non-small cell lung cancer ....

Botox rival offers rebate

Mar 13, 2010 3:50am

Medicis, maker of anti-wrinkle shot Dysport, has introduced a new marketing campaign targeting Botox, its better-known competitor....

Endo Pharma hires former Nora Therapeutics and J&J exec McHugh as chief operating officer

Mar 12, 2010 11:41pm

Endo Pharmaceuticals Holdings Inc. said Friday it hired former Nora Therapeutics CEO Julie McHugh as its new chief operating officer....

FDA rules out Fosamax, thigh fracture link

Mar 12, 2010 7:23pm

U.S. regulators said they have found no link between oral bisphosphonate osteoporosis medications such as Merck & Co Inc.'s Fosamax and certain thigh bone fractures....

FDA warning: some patients cannot process Plavix

Mar 12, 2010 3:10pm

In this July 28, 2006 file photo, blood thinner medication Plavix is shown in New York....

Chelsea Therapeutics 4Q loss narrows on costs

Mar 12, 2010 10:48am

Chelsea Therapeutics International Ltd. said Wednesday its loss narrowed on lower operating expenses as the company concluded several studies....

Glenn Close latest to have genes mapped

Mar 12, 2010 6:36am

A A Study: Bone-strengthening drugs could backfire Two small studies suggest that a small percentage of patients who use certain drugs to prevent bone loss for more than five years could be at greater risk for a rare type of hip fracture....

Pfizer says Sutent fails in breast cancer studies

Mar 12, 2010 2:31am

Pfizer Inc. said Thursday the cancer drug Sutent did not meet key goals in two late-stage studies focusing on advanced breast cancer....

Merck: Study of Vytorin effectiveness to continue

Mar 11, 2010 10:06pm

Researchers will continue a study of a controversial Merck & Co. cholesterol drug after safety monitors decided data so far indicate the drug is safe and effective, the company said Thursday....

4ie6

Mar 11, 2010 5:42pm

In the docs, Johnson, the owner of the New York Jets , is asking the court to appoint him Special Administrator of Casey's estate....

"Personal" study shows gene maps can spot disease

Mar 11, 2010 1:22pm

Two studies published on Wednesday show it is possible to sequence the entire gene maps of families with inherited diseases and pinpoint the offending bit of DNA....

BOTOX® (OnabotulinumtoxinA) Receives FDA Approval for Treatment...

Mar 11, 2010 9:20am

Allergan, Inc. ) today announced that the United States Food and Drug Administration has approved BOTOX for the treatment of increased muscle stiffness in the elbow, wrist and fingers in adults with upper limb spasticity....

Astra boosts generic exposure with Torrent deal

Mar 11, 2010 5:08am

AstraZeneca PLC announced a supply partnership with India's Torrent Pharmaceuticals on Thursday, its first such link with a generic drugmaker as it seeks to boost its presence in emerging markets and counter patent losses on blockbuster medicines....

FDA approves InterMune lung drug

Mar 11, 2010 1:00am

The U.S. Food and Drug Administration approved an InterMune Inc. new drug application Tuesday for treatment of people with idiopathic pulmonary fibrosis....

CDC uses shopper-card data to trace salmonella

Mar 10, 2010 8:57pm

In this photo taken March 9, 2010, Raymond Cirimele, 55, displays his Costco membership card outside his home in Chicago....